Manjeet Chadha, MD

ACR Appropriateness Criteria® Ductal Carcinoma in Situ

June 15, 2015

Seth A. Kaufman, MD
Eleanor E. R. Harris, MD
Lisa Bailey, MD
Manjeet Chadha, MD
Sharon C. Dutton, MD
Gary M. Freedman, MD
Sharad Goyal, MD
Michele Y. Halyard, MD
Kathleen C. Horst, MD
Kristina L. M. Novick, MD
Catherine C. Park, MD
W. Warren Suh, MD
Deborah Toppmeyer, MD
Jennifer Zook, MD
Bruce G. Haffty, MD

Management of ductal carcinoma in situ (DCIS) commonly involves excision, radiotherapy, and hormonal therapy. Radiotherapy is employed for local control in breast conservation. Evidence is evolving for several radiotherapy techniques exist beyond standard whole-breast irradiation.

READ >>
Add new comment

Managing a Small Recurrence in the Previously Irradiated Breast

October 23, 2009

Manjeet Chadha, MD
Mark Trombetta, MD
Susan Boolbol, MD
Michael P. Osborne, MD, MSurg, FRCS, FACS

Breast cancer is the most common newly diagnosed malignancy among American women. In 2008, an estimated 182,460 new cases of invasive breast cancer, and an additional 67,770 cases of in situ cancer were diagnosed. Approximately 40,480 women will die from breast cancer each year.

READ >>
Add new comment